Laura’s Hope operates under the legal umbrella of the Huntington Society of Canada, which provides administrative support and connection to affiliated associations around the world. It functions as an independent component of the Society’s NAVIGATOR Coalition, (their research arm), which provides direct access to the global research community. It has its own Board of Governors, which includes representation from both the scientific and business communities.
A separate Scientific Steering Committee vets research requests and proposals on behalf of the Board of Governors.
Funding may be made available to clinical research initiatives anywhere in the world that will tangibly advance the goals of Laura’s Hope.
The committee members are:
Dr. Marcy MacDonald
Molecular Neurogenetics
Harvard Medical / Massachusetts General
(on team that identified the gene in 1993)
Dr. Harold Robertson
Carnegie and Rockefeller Professor
Dept. of Pharmacology
Dalhousie University
Dr. Steven Hersch
Neurology - Harvard Medical / Mass. General
Huntington Society of America Leader;
Medical /Scientific Advisory Committee
Dr. Gillian Bates
Professor of Neurogenetics
Kings College, London
(developed 1st animal model for Huntington’s)
Dr. Michael Hayden
Professor Medical Genetics, and
Director; Molecular Medicine & Therapies
University of British Columbia
(one of the world’s top Huntington researchers)
This pool of global expertise helps ensure that funding is invested for maximum impact.
Medical /Scientific Advisory Committee The Huntington’s community is pioneering globally co-ordinated research in a drive for an immediate treatment.
